News tagged with clopidogrel
Related topics: patients , heart attack , thrombosis , aspirin , blood clots
TARDIS trial seeks new dimension in stroke treatment
People who suffer from acute stroke or Transient Ischaemic Attack (TIA, a mini stroke) could get better treatment in the future thanks to the expansion of a large clinical trial of a new combination of drugs led by researchers ...
Cardiology
Oct 17, 2011 |
not rated yet |
0
Increased risk of bleeding with combined use of SSRIs and antiplatelet therapy after heart attacks
Heart attack patients taking selective serotonin reuptake inhibitors (SSRIs) in combination with antiplatelet therapy -- acetylsalicylic acid (ASA), clopidogrel or both (dual antiplatelet therapy) -- are at higher risk of ...
Medical research
Sep 26, 2011 |
not rated yet |
0
Study examines platelet function testing for guiding antithrombotic treatment before PCI procedures
Among patients with acute coronary syndromes undergoing a procedure such as angioplasty, those who received platelet function tests before receiving antithrombotic therapy to determine appropriate clopidogrel dosing and who ...
Diseases, Conditions, Syndromes
Sep 20, 2011 |
not rated yet |
1
Even low-dose aspirin may increase risk of GI bleeding
The risk of gastrointestinal (GI) bleeding needs to be considered when determining the potential preventive benefits associated with low-dose aspirin for cardiovascular disease and cancer. According to a new study in Clinical Ga ...
Medical research
Sep 12, 2011 |
not rated yet |
0
Lower achieved platelet reactivity associated with better cardiovascular
Compared to patients who had persistently high platelet reactivity, those who achieved low platelet reactivity, according to the VerifyNow P2Y12 Test, had a reduced incidence of cardiovascular death, heart attack and stent ...
Cardiology
Aug 30, 2011 |
not rated yet |
0
Assessing the most appropriate duration of dual antiplatelet therapy after coronary stenting
A randomised multicentre open-label study evaluating the efficacy and safety of prolonged antiplatelet therapy in patients with coronary disease has found that 24 months' duration of dual therapy is no better than six months ...
Cardiology
Aug 30, 2011 |
not rated yet |
0
ESC calls for greater awareness of potential for adverse events from bleeding as a result of PCI
The European Society of Cardiology (ESC Working Group on Thrombosis) is calling for greater attention to be paid by health care staff to reducing bleeding in patients with acute coronary syndromes (ACS) undergoing percutaneous ...
Cardiology
Jun 30, 2011 |
not rated yet |
0
New study suggests potent antiplatelet drug effective with low-dose aspirin
When taken with higher doses of aspirin (more than 300 milligrams), the experimental antiplatelet drug ticagrelor was associated with worse outcomes than the standard drug, clopidogrel, but the opposite was true with lower ...
Cardiology
Jun 27, 2011 |
5 / 5 (1) |
0
Omega-3 and blood-thinning drugs impact clotting process
Researchers in Poland have discovered that combining omega-3 fatty acids with two blood-thinning drugs, aspirin and clopidogrel, changed the process of blood clotting, potentially helping reduce the risk of ...
Cardiology
Jun 21, 2011 |
not rated yet |
0
One in five heart-attack deaths could be prevented with new drug
Robert Storey, Professor of Cardiology at the University of Sheffield's Department of Cardiovascular Science, presented findings today that confirm one in five deaths in the year following a heart attack could be prevented ...
Cardiology
Jun 13, 2011 |
not rated yet |
0
|
Undertreatment of cardiovascular disease in rheumatoid arthritis patients following a heart attack
Results of a study, involving 98,454 patients demonstrated that at 30 days following their first heart attack, RA patients were approximately 20% less likely to be prescribed standard MI treatments, such as statins and betablockers, ...
Diseases, Conditions, Syndromes
May 27, 2011 |
not rated yet |
0
Omega-3 may cut risk of artery disease, heart attacks for patients with stents
Omega-3 fatty acids, combined with two blood-thinning drugs, significantly changed the blood-clotting process and may reduce the risk of heart attacks in patients with stents in their heart arteries, according to research ...
Cardiology
May 26, 2011 |
4 / 5 (1) |
0
|
